Company Profile
Lenz Therapeutics Inc Stock Price, News & Analysis
- Ticker:
- LENZ
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
5.70 USD (+4.01%)
Close
Last updated: July 27, 2026
224M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, LENZ closed up 4.01% at $5.70. No new same-company headline was identified in the current news window.
Company overview
Business overview
LENZ Therapeutics is an ophthalmology company focused on presbyopia and eye-care treatments. Its story is centered on bringing a differentiated eye-health product to a large but competitive market.
Geographic Base and Sector Classification
LENZ Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in ophthalmology biotechnology.
Business Model Characteristics
The company depends on clinical and commercial progress, regulatory milestones, and the ability to win adoption in eye care. Investors watch launch readiness and market penetration.
Position Within the Biotechnology Landscape
LENZ occupies a focused ophthalmology niche within biotech. It is catalyst-sensitive because the company is still proving whether the eye-care franchise can scale.
Future catalysts
LENZ’s catalysts are cataract / ophthalmology platform updates and any commercialization or clinical step that clarifies the company’s path. The market will care about whether the eye-care story keeps building.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
OCUL · Source: Ocular Therapeutix
- 02
- 03
- 04
Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium
KPRX · Source: Kiora Pharmaceuticals
- 05
Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences
OCUL · Source: Ocular Therapeutix
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Lenz Therapeutics Inc (LENZ)?
Lenz Therapeutics Inc (LENZ) most recently closed at 5.70 USD, a +4.01% move versus the previous session.
What is the market cap of Lenz Therapeutics Inc (LENZ)?
Lenz Therapeutics Inc currently has a market capitalization of 224M USD on BioPharmSignal.
What does Lenz Therapeutics Inc do?
LENZ Therapeutics is an ophthalmology company focused on presbyopia and eye-care treatments. Its story is centered on bringing a differentiated eye-health product to a large but competitive market.
On which exchange is LENZ stock listed?
Lenz Therapeutics Inc (LENZ) is associated with NASDAQ, United States, Biopharma.
What is Therapeutics?
LENZ Therapeutics is an ophthalmology company focused on presbyopia and eye-care treatments.
Which conditions is Lenz Therapeutics Inc targeting with Therapeutics?
Lenz Therapeutics Inc is associated with ophthalmology based on its company overview and current catalyst commentary.
How does Lenz Therapeutics Inc describe recent progress with Therapeutics?
LENZ’s catalysts are cataract / ophthalmology platform updates and any commercialization or clinical step that clarifies the company’s path. The market will care about whether the eye-care story keeps building.
What future catalysts are investors watching for Lenz Therapeutics Inc?
LENZ’s catalysts are cataract / ophthalmology platform updates and any commercialization or clinical step that clarifies the company’s path. The market will care about whether the eye-care story keeps building.